Journal of SAFOMS

Register      Login

VOLUME 5 , ISSUE 2 ( July-December, 2017 ) > List of Articles


Evaluation of Incompletely Staged Ovarian Malignancy: A Study in Western India

Anusha Kamath, Pariseema Dave, Meeta Mankad

Citation Information : Kamath A, Dave P, Mankad M. Evaluation of Incompletely Staged Ovarian Malignancy: A Study in Western India. J South Asian Feder Menopause Soc 2017; 5 (2):133-137.

DOI: 10.5005/jp-journals-10032-1122

License: CC BY 3.0

Published Online: 01-01-2011

Copyright Statement:  Copyright © 2017; The Author(s).



Incomplete initial surgery complicates subsequent management of ovarian tumors. This study aimed to study demographic and clinical factors associated with incompletely staged ovarian tumor patients.

Materials and methods

Twenty five patients who had undergone incomplete staging surgery for ovarian tumors outside Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India, were included in this study. Their demographic and clinical features were studied in detail. Patients were either subjected to restaging or were referred for chemotherapy initially.


Mean age of patients was 42 years (23—60 years); 64% of patients had abdominal pain as initial complaint; 64% patients were operated initially using a transverse incision. Only four patients were managed laparoscopically initially, others by laparotomy. Single/part of one ovary was removed in 60% of patients as part of initial surgery. Infundibulopelvic ligament was tied distally in 40% of patients. Omentectomy (Om) and lymphadenectomy were not done in most of the patients. Nineteen patients were found to have malignancy on final histopathological examination; 3 borderline malignancy; 1 granulosa cell tumor; and 2 benign tumors; 52% (n = 13) patients were subjected to chemotherapy; 4% (n = 1) were observed, and rest underwent restaging procedures.


Incompletely staged ovarian tumor patients, especially those with malignant histopathology, should be managed by gynecologic oncologists. The management needs to be individualized and cannot be a blanket therapy.

How to cite this article

Kamath A, Dave P, Mankad M. Evaluation of Incompletely Staged Ovarian Malignancy: A Study in Western India. J South Asian Feder Menopause Soc 2017;5(2):133-137.

  1. Two year report of population based cancer registries, 2004-2005. Incidence and distribution of cancer. Bengaluru: Indian Council of Medical Research (ICMR); 2008.
  2. Changing trends in incidence of ovarian cancer — the Indian scenario. Asian Pac J Cancer Prev 2009 Jan;10(6):1025-1030.
  3. Consolidated report of population based cancer registries 2001-2004. Bengaluru: Indian Council of Medical Research; 2006.
  4. Cancer statistics, 2006. CA Cancer J Clin 2006 Mar-Apr;56(2):106-130.
  5. Clinical practice guidelines in oncology. Ovarian Cancer. Fort Washington (PA): NCCN; 2014. p. 2.
  6. Study of ‘patterns of care' of ovarian cancer patients in a specialized cancer institute in Kolkata, eastern India. Indian J Cancer 2009 Jan-Mar;46(1):28-33.
  7. Understanding the problem of inadequately staging early ovarian cancer. Eur J Cancer 2010 Mar;46(5):880-884.
  8. The impact of specialist training for surgery in ovarian cancer. Int J Gynecol Cancer 2000 Jan-Feb;10(Suppl 1):16-18.
  9. What constitutes the “optimal” treatment environment of women with gynecologic cancer? Gynecol Oncol 2003 Apr;89(1):1-3.
  10. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 2006 Feb;106(3):589-598.
  11. Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery. Surg Oncol 2012 Mar;21(1):31-35.
  12. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 2006 Feb;98(3):172-180.
  13. Surgical outcomes in women with ovarian cancer. Can J Surg 2008 Oct;51(5):346-354.
  14. Staging laparotomy in early ovarian cancer. JAMA 1983 Dec;250(22):3072-3076.
  15. If the mountain does not come to Mohammad: the significance of guest operations for early stage ovarian cancer. J Gynecol Surg 2014 Oct;30(5):265-272.
  16. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor. World J Surg Oncol 2013 Jan;11:13.
  17. Role of a risk of malignancy index in clinical approaches to adnexal masses. Asian Pac J Cancer Prev 2014 Oct;15(18):7793-7797.
  18. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass. Gynec Oncol 2012 Nov;127(2):379-383.
  19. Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study. Br J Cancer 2016 Aug;115(5):542-548.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.